Finance

Lists
TLIK:FRA
Arzneiwerk VIDA AG
€0.21
0.00%
(0.00) 1D
Jul 21, 12:36:13 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for TLIK...
Mkt. cap
1.31M
Avg. vol.
79.00
Volume
0.00
52-wk high
€0.59
52-wk low
€0.00
EPS
-€0.09
No. of employees
1
Mkt. cap
1.31M
Avg. vol.
79.00
Volume
0.00
52-wk high
€0.59
52-wk low
€0.00
EPS
-€0.09
No. of employees
1
News stories
From sources across the web
Profile
TELES AG Informationstechnologien is a provider of equipment and services to fixed, fixed-mobile convergence, and Next Generation Networking service providers. The company was founded in 1983 as TELES GmbH by Professor Dr.-Ing. Sigram Schindler in close cooperation with Technische Universität Berlin. Professor Schindler lectured in telecommunications at the university until 1998. In 1997, he was voted High-Tech Manager of the Year by Manager Magazine in Germany. Active in VoIP technology development since 1996, the company's main development and operational focus lies in the areas of IMS and NGN. TELES supplies service providers with complete Class 4 and Class 5 NGN Softswitch. TELES NGN is a standard based, scalable architecture aimed at minimizing integration time and allowing quick deployment. It includes hosted voice functionality which enables residential VoIP services, hosted PBX services, Fixed-Mobile-Convergence, IP Trunking, and additional value added applications. Classical NGN/PSTN applications like Wholesale, Long Distance, and NGN backbone services are also available with this. Wikipedia
About Arzneiwerk VIDA AG
CEOOliver Olbrich
Employees1
Founded1983
Headquarters-
SectorHealth care provider
Websitearzneiwerk.ag
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
28.22K
46.00
46.00
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.36K
20.86K
20.86K
-
Operating expense
266.00K
-13.70K
-13.70K
-
Total operating expenses
266.00K
-13.70K
-13.70K
-
Operating income
-237.78K
13.74K
13.74K
-
Other non operating income
-2.00
-40.76K
-40.76K
-
EBT including unusual items
-302.68K
-40.71K
-40.71K
-
EBT excluding unusual items
-302.68K
-58.06K
-58.06K
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
244.08K
-34.87K
-34.87K
-
Net income
-302.68K
-40.71K
-40.71K
-
Net profit margin
-1,072.56%
-88,504.35%
-88,504.35%
-75,993.00%
Earnings per share
-
-
-
-
Interest and investment income
-
40.00
40.00
-
Interest expense
-64.90K
-31.08K
-31.08K
-
Net interest expenses
-64.90K
-31.04K
-31.04K
-
Depreciation and amortization charges
557.00
316.00
316.00
-
EBITDA
-237.22K
14.06K
14.06K
-
Gain or loss from assets sale
7.98K
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer